Cargando…
Efficacy and Effectiveness of the ProSomnus® [IA] Sleep Device for the Treatment of Obstructive Sleep Apnea: EFFECTS Study
Objectives To evaluate the effectiveness of a new mandibular advancement device (MAD) (Prosomnus® [IA] Sleep Device, Prosomnus Sleep Technologies, Pleasanton CA) fitted with a compliance tracker as a first-line treatment in a population of patients with mild to severe obstructive sleep apnea (OSA)....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252976/ https://www.ncbi.nlm.nih.gov/pubmed/34249542 http://dx.doi.org/10.7759/cureus.15391 |
_version_ | 1783717411791306752 |
---|---|
author | Stern, Jordan Lee, Kiwon Kuhns, Dave Martinez-Kratz, Jesse F |
author_facet | Stern, Jordan Lee, Kiwon Kuhns, Dave Martinez-Kratz, Jesse F |
author_sort | Stern, Jordan |
collection | PubMed |
description | Objectives To evaluate the effectiveness of a new mandibular advancement device (MAD) (Prosomnus® [IA] Sleep Device, Prosomnus Sleep Technologies, Pleasanton CA) fitted with a compliance tracker as a first-line treatment in a population of patients with mild to severe obstructive sleep apnea (OSA). Methods Treatment effectiveness was measured using pre and post-treatment home sleep testing (HST) and validated sleep and quality of life questionnaires. Mean disease alleviation (MDA) was calculated to compare the treatment effectiveness of MAD to historical continuous positive airway pressure (CPAP) effectiveness data. Results MAD was found to be an effective first-line treatment for patients with mild, moderate, and severe sleep apnea with excellent compliance rates, similar to or better than CPAP, and an equal or better MDA of 56.7% compared to literature values of 50% for CPAP. Conclusions MAD should be considered an effective first-line treatment for patients with mild and moderate sleep apnea and for severe sleep apnea for patients who prefer, refuse, or are not candidates for CPAP. |
format | Online Article Text |
id | pubmed-8252976 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-82529762021-07-09 Efficacy and Effectiveness of the ProSomnus® [IA] Sleep Device for the Treatment of Obstructive Sleep Apnea: EFFECTS Study Stern, Jordan Lee, Kiwon Kuhns, Dave Martinez-Kratz, Jesse F Cureus Otolaryngology Objectives To evaluate the effectiveness of a new mandibular advancement device (MAD) (Prosomnus® [IA] Sleep Device, Prosomnus Sleep Technologies, Pleasanton CA) fitted with a compliance tracker as a first-line treatment in a population of patients with mild to severe obstructive sleep apnea (OSA). Methods Treatment effectiveness was measured using pre and post-treatment home sleep testing (HST) and validated sleep and quality of life questionnaires. Mean disease alleviation (MDA) was calculated to compare the treatment effectiveness of MAD to historical continuous positive airway pressure (CPAP) effectiveness data. Results MAD was found to be an effective first-line treatment for patients with mild, moderate, and severe sleep apnea with excellent compliance rates, similar to or better than CPAP, and an equal or better MDA of 56.7% compared to literature values of 50% for CPAP. Conclusions MAD should be considered an effective first-line treatment for patients with mild and moderate sleep apnea and for severe sleep apnea for patients who prefer, refuse, or are not candidates for CPAP. Cureus 2021-06-02 /pmc/articles/PMC8252976/ /pubmed/34249542 http://dx.doi.org/10.7759/cureus.15391 Text en Copyright © 2021, Stern et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Otolaryngology Stern, Jordan Lee, Kiwon Kuhns, Dave Martinez-Kratz, Jesse F Efficacy and Effectiveness of the ProSomnus® [IA] Sleep Device for the Treatment of Obstructive Sleep Apnea: EFFECTS Study |
title | Efficacy and Effectiveness of the ProSomnus® [IA] Sleep Device for the Treatment of Obstructive Sleep Apnea: EFFECTS Study |
title_full | Efficacy and Effectiveness of the ProSomnus® [IA] Sleep Device for the Treatment of Obstructive Sleep Apnea: EFFECTS Study |
title_fullStr | Efficacy and Effectiveness of the ProSomnus® [IA] Sleep Device for the Treatment of Obstructive Sleep Apnea: EFFECTS Study |
title_full_unstemmed | Efficacy and Effectiveness of the ProSomnus® [IA] Sleep Device for the Treatment of Obstructive Sleep Apnea: EFFECTS Study |
title_short | Efficacy and Effectiveness of the ProSomnus® [IA] Sleep Device for the Treatment of Obstructive Sleep Apnea: EFFECTS Study |
title_sort | efficacy and effectiveness of the prosomnus® [ia] sleep device for the treatment of obstructive sleep apnea: effects study |
topic | Otolaryngology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252976/ https://www.ncbi.nlm.nih.gov/pubmed/34249542 http://dx.doi.org/10.7759/cureus.15391 |
work_keys_str_mv | AT sternjordan efficacyandeffectivenessoftheprosomnusiasleepdeviceforthetreatmentofobstructivesleepapneaeffectsstudy AT leekiwon efficacyandeffectivenessoftheprosomnusiasleepdeviceforthetreatmentofobstructivesleepapneaeffectsstudy AT kuhnsdave efficacyandeffectivenessoftheprosomnusiasleepdeviceforthetreatmentofobstructivesleepapneaeffectsstudy AT martinezkratzjessef efficacyandeffectivenessoftheprosomnusiasleepdeviceforthetreatmentofobstructivesleepapneaeffectsstudy |